Cytokine immunotherapy during bacterial pneumonia: from benchtop to bedside

Seminars in Respiratory Infections
T A Moore, T J Standiford

Abstract

Bacterial pneumonia is a leading cause of morbidity and mortality within the United States and abroad. Although broad-spectrum antibiotic regiments have led to advances in the treatment of pneumonia, this approach has resulted in the recent emergence of multidrug-resistant bacteria. This adverse effect of aggressive antibiotic therapy underscores the importance for understanding the host inflammatory response to pulmonary bacterial infections. This knowledge can then lead to the development of therapeutic modalities aimed at augmenting host responses, resulting in enhanced resolution of bacterial pneumonia. Ideally, future treatment would combine immunoadjuvant and conventional antibiotic therapy for the treatment of life-threatening bacterial pneumonia. The detailed study of several distinct animal models of bacterial pneumonia has identified cytokines involved in eradication of bacteria deposited within the pulmonary airspace. Furthermore, these studies have led to promising preliminary findings in animal models using therapeutic cytokine immunotherapy.

Citations

Apr 12, 2003·Current Opinion in Pulmonary Medicine·Julie AndrewsNandini Shetty
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Sylvia KnappTom van der Poll
Dec 23, 2006·American Journal of Respiratory and Critical Care Medicine·Mark C DessingTom van der Poll
Dec 12, 2003·American Journal of Respiratory and Critical Care Medicine·Joseph P Mizgerd
May 6, 2006·American Journal of Respiratory Cell and Molecular Biology·Mohamed S ArredouaniLester Kobzik
Feb 4, 2016·International Journal of Molecular Sciences·Kok-Khun YongShun-Fa Yang
Jan 7, 2006·Medical Mycology·Karen L WozniakPaul L Fidel
Aug 23, 2007·Cellular Microbiology·Mark C DessingTom van der Poll
Sep 10, 2005·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Marie-H MonfilsJeffrey A Kleim
Dec 1, 2005·Human Nature : an Interdisciplinary Biosocial Perspective·Dominic D P Johnson
Nov 6, 2008·Social Cognitive and Affective Neuroscience·Rebecca SaxeJohn Gabrieli
Sep 28, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Pin-Kuei FuJen-Kun Chen
Mar 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marieke A D van ZoelenTom van der Poll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.